Skip to main content
. 2013 Feb 18;8(2):e56865. doi: 10.1371/journal.pone.0056865

Figure 4. MCL1 and BCL2A1 protein expression in IL-17A-treated DC.

Figure 4

(A) Intracellular expression of MCL1 and BCL2A1 in DC treated (white) or not (gray) with IL-17A, at day 7, representative of n>3, SD<2%. (B,C) Western blot analysis of BCL2A1 versus actin protein expressions in DC cultured with indicated cytokines, lyzed at day 5 for 4 donors (4) to (7), in separated experiments.